Fundraising FoxStemgenics
Seattle, US · Washington corporation
Find your way into Stemgenics
Sign up to see every warm intro you have to Stemgenics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stemgenics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
FS
Frederick S HagenExecutive
MH
Mushegh HovhannisyanExecutive
AA
Andranik AprikyanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 3 rounds · 2013–2018
▶$445KraisedJul 2018 · 8 investors · BiotechnologyRule 506(b)
▶$445KraisedJul 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mushegh HovhannisyanExecutive Officer, Director
- Frederick S HagenExecutive Officer, Director
- Andranik AprikyanExecutive Officer, Director
- Anush OganesianDirector
- Offering amount
- $20M
- Amount sold
- $445K
- Proceeds to insiders
- $1.2M
- Placement agents
- Endeavor Capital Management Holdings, Frederick S. Hagen
- First sale
- Jun 2018
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$1.8MraisedJan 2018 · 39 investors · BiotechnologyRule 506(b)
▶$1.8MraisedJan 2018 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frederick S HagenExecutive Officer, Director
- Andranik AprikyanExecutive Officer, Director
- Mushegh HovhannisyanExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Dec 2015
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$1.1MraisedJan 2014 · 13 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJan 2014 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mushegh HovhannisyanExecutive Officer, Director
- Frederick HagenExecutive Officer, Director
- Andranik AprikyanExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Proceeds to insiders
- $150K
- First sale
- Dec 2013
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Stemgenics raised?
- Stemgenics has disclosed $3.3M raised across 3 rounds.
- Where is Stemgenics headquartered?
- Stemgenics is headquartered in Seattle, US.